These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 10171055)

  • 21. Drug-free workplace programmes: New Zealand perspective.
    Nolan S
    Forensic Sci Int; 2008 Jan; 174(2-3):125-32. PubMed ID: 17467938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symposium on drug testing in the workplace. Committee on public health and the Section on Occupational Medicine, New York Academy of Medicine, February 3, 1988.
    Bull N Y Acad Med; 1989 Feb; 65(2):163-242. PubMed ID: 2611450
    [No Abstract]   [Full Text] [Related]  

  • 23. Solutions to workplace substance abuse: prevention and treatment strategies.
    Apgar KR
    Issue Brief (Inst Health Care Costs Solut); 2003; 2(1):1-16. PubMed ID: 12825604
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug & alcohol testing. Screening for safety.
    Current WF
    Occup Health Saf; 2001 Aug; 70(8):24, 26. PubMed ID: 11523281
    [No Abstract]   [Full Text] [Related]  

  • 25. Why drugs and safety don't mix.
    Cholakis P
    Occup Health Saf; 2006 Aug; 75(8):28, 31-2. PubMed ID: 16944799
    [No Abstract]   [Full Text] [Related]  

  • 26. Overview on drug and alcohol testing in the workplace.
    Hanson M
    Bull Narc; 1993; 45(2):3-44. PubMed ID: 7920541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral fluid testing: six considerations.
    Masterson LH
    Occup Health Saf; 2003 Aug; 72(8):78-80, 89. PubMed ID: 12945510
    [No Abstract]   [Full Text] [Related]  

  • 28. [Substance abuse by health personnel].
    Zierau F
    Ugeskr Laeger; 2002 Nov; 164(47):5501-5. PubMed ID: 12523024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug testing as part of the war on drugs.
    Gerson B; Subramaniam S
    Clin Lab Med; 1998 Dec; 18(4):781-803, xi. PubMed ID: 9891615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations.
    Bush DM
    Forensic Sci Int; 2008 Jan; 174(2-3):111-9. PubMed ID: 17434274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Random drug tests at work: the probability of identifying frequent and infrequent users of illicit drugs.
    DuPont RL; Griffin DW; Siskin BR; Shiraki S; Katze E
    J Addict Dis; 1995; 14(3):1-17. PubMed ID: 8555274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Case studies of drug testing in the workplace.
    Blume S; Cannella JM; Muir E; Stein P; Weihenmeyer E
    Bull N Y Acad Med; 1989 Feb; 65(2):215-42. PubMed ID: 2611457
    [No Abstract]   [Full Text] [Related]  

  • 33. Effectiveness and benefit-cost of peer-based workplace substance abuse prevention coupled with random testing.
    Miller TR; Zaloshnja E; Spicer RS
    Accid Anal Prev; 2007 May; 39(3):565-73. PubMed ID: 17125723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laboratory tests for rapid screening of drugs of abuse in the workplace: a review.
    Schwartz RH; Clark HW; Meek PS
    J Addict Dis; 1993; 12(2):43-56. PubMed ID: 8476942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substance abuse and the uninsured worker in the United States.
    Galvin DM; Miller TR; Spicer RS; Waehrer GM
    J Public Health Policy; 2007; 28(1):102-17. PubMed ID: 17363941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Workplace substance abuse impairment: the occupational health care provider's role.
    McAndrew KG; McAndrew SJ
    AAOHN J; 2000 Jan; 48(1):32-45; quiz 46-7. PubMed ID: 15635918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?
    Manchikanti L; Manchukonda R; Pampati V; Damron KS; Brandon DE; Cash KA; McManus CD
    Pain Physician; 2006 Apr; 9(2):123-9. PubMed ID: 16703972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new challenge for drug-free workplace programs.
    DuPont RL; Martin DM; Skipper GE
    Occup Health Saf; 2012 Feb; 81(2):32, 34. PubMed ID: 22435238
    [No Abstract]   [Full Text] [Related]  

  • 39. Just say 'No'. Policies, procedures, and legal considerations for maintaining a drug-free work-place environment.
    Slogoff RJ
    Provider; 1998 Jan; 24(1):49-50. PubMed ID: 10175136
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug screening in the workplace: use, abuse and implications.
    Grabowski J; Silverman PB
    NIDA Res Monogr; 1989; 95():225-31. PubMed ID: 2640968
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.